Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 1
1994 1
1996 2
1997 1
1998 2
1999 2
2000 2
2001 3
2002 2
2003 2
2004 1
2005 1
2006 2
2007 1
2008 2
2009 1
2010 2
2011 1
2012 1
2014 3
2015 7
2016 3
2017 1
2020 2
2021 2
2022 1
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
[Infective endocarditis : In-hospital mortality predictive factors].
Safia O, Asma J, Hana H, Sarra J, Aymen Z, Mouna J, Amal M, Rym BK. Safia O, et al. Among authors: sarra j. Ann Cardiol Angeiol (Paris). 2024 Apr;73(2):101740. doi: 10.1016/j.ancard.2024.101740. Epub 2024 Feb 27. Ann Cardiol Angeiol (Paris). 2024. PMID: 38417204 French.
Genetic variants of CTLA4 are associated with clinical outcome of patients with multiple myeloma.
Gonzalez-Montes Y, Rodriguez-Romanos R, Villavicencio A, Osca-Gelis G, González-Bártulos M, Llopis F, Clapes V, Oriol A, Sureda A, Escoda L, Sarrà J, Garzó A, Lloveras N, Díez I, Granada I, Gallardo D. Gonzalez-Montes Y, et al. Among authors: sarra j. Front Immunol. 2023 Apr 12;14:1158105. doi: 10.3389/fimmu.2023.1158105. eCollection 2023. Front Immunol. 2023. PMID: 37122695 Free PMC article.
Multiple myeloma and hyperammonemic encephalopathy: review of 27 cases.
Lora-Tamayo J, Palom X, Sarrá J, Gasch O, Isern V, Fernández de Sevilla A, Pujol R. Lora-Tamayo J, et al. Among authors: sarra j. Clin Lymphoma Myeloma. 2008 Dec;8(6):363-9. doi: 10.3816/CLM.2008.n.054. Clin Lymphoma Myeloma. 2008. PMID: 19064403 Review.
CD200 genotype is associated with clinical outcome of patients with multiple myeloma.
Gonzalez-Montes Y, Osca-Gelis G, Rodriguez-Romanos R, Villavicencio A, González-Bártulos M, Llopis F, Clapes V, Oriol A, Sureda A, Escoda L, Sarrà J, Garzó A, Lloveras N, Gómez B, Granada I, Gallardo D. Gonzalez-Montes Y, et al. Among authors: sarra j. Front Immunol. 2024 Feb 22;15:1252445. doi: 10.3389/fimmu.2024.1252445. eCollection 2024. Front Immunol. 2024. PMID: 38455039 Free PMC article.
[Low-molecular-weight heparins].
Rocha E, Páramo JA, Sarrá J. Rocha E, et al. Among authors: sarra j. Med Clin (Barc). 1993 Apr 24;100(16):620-7. Med Clin (Barc). 1993. PMID: 8388527 Review. Spanish. No abstract available.
Treatment patterns and outcomes in real-world transplant-ineligible patients newly diagnosed with multiple myeloma.
Cejalvo MJ, Bustamante G, González E, Vázquez-Álvarez J, García R, Ramírez-Payer Á, Pérez-Persona E, Abella E, Garzón S, García A, Jarque I, González MS, Sampol A, Motlló C, Martí JM, Alcalá M, Duro R, González Y, Sastre JL, Sarrà J, Lostaunau G, López R, de la Rubia J. Cejalvo MJ, et al. Among authors: sarra j. Ann Hematol. 2021 Jul;100(7):1769-1778. doi: 10.1007/s00277-021-04529-5. Epub 2021 Apr 22. Ann Hematol. 2021. PMID: 33885924
Renal involvement in non-malignant IgM gammopathy.
Ramos R, Poveda R, Sarrá J, Domingo A, Carreras L, Grinyó JM. Ramos R, et al. Among authors: sarra j. Nephrol Dial Transplant. 2007 Feb;22(2):627-30. doi: 10.1093/ndt/gfl709. Epub 2006 Dec 12. Nephrol Dial Transplant. 2007. PMID: 17164317 No abstract available.
Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- and high-risk myeloma.
Goicoechea I, Puig N, Cedena MT, Burgos L, Cordón L, Vidriales MB, Flores-Montero J, Gutierrez NC, Calasanz MJ, Ramos MM, Lara-Astiaso D, Vilas-Zornoza A, Alignani D, Rodriguez I, Sarvide S, Alameda D, Garcés JJ, Rodriguez S, Fresquet V, Celay J, Garcia-Sanz R, Martinez-Lopez J, Oriol A, Rios R, Martin-Sanchez J, Martinez-Martinez R, Sarra J, Hernandez MT, de la Rubia J, Krsnik I, Moraleda JM, Palomera L, Bargay J, Martinez-Climent JA, Orfao A, Rosiñol L, Mateos MV, Lahuerta JJ, Blade J, San Miguel J, Paiva B. Goicoechea I, et al. Among authors: sarra j. Blood. 2021 Jan 7;137(1):49-60. doi: 10.1182/blood.2020006731. Blood. 2021. PMID: 32693406 Free article. Clinical Trial.
Front-line fludarabine-cyclophosphamide-rituximab (FCR) in 110 patients with chronic lymphocytic leukaemia (CLL): real-life experience with long-term outcomes, toxicities and responses to second-line therapies.
Oliveira AC, Roncero JM, Ferrá C, Do Nascimento J, Rodriguez-Luaces M, Encuentra M, Domingo-Domenech E, López P, Gallardo D, Ribera JM, Sarrá J, Sureda A, González-Barca E. Oliveira AC, et al. Among authors: sarra j. Int J Hematol. 2023 Mar;117(3):388-397. doi: 10.1007/s12185-022-03488-5. Epub 2022 Nov 30. Int J Hematol. 2023. PMID: 36449134
48 results